ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

MREO Mereo BioPharma Group PLC

3.17
0.02 (0.63%)
最終更新日: 02:41:10
15分遅延
名称 銘柄コード 市場 種別
Mereo BioPharma Group PLC MREO NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.02 0.63% 3.17 02:41:10
始値 安値 高値 終値 前日終値
3.18 3.11 3.24 3.15
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0320:30GLOBEMereo BioPharma to Participate in Fireside Chat at the 23rd..
2024/3/2805:01GLOBEMereo BioPharma Reports Full Year 2023 Financial Results and..
2024/3/0521:30GLOBEMereo BioPharma to Participate in Fireside Chat at the..
2024/2/1006:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1006:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1006:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1006:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0706:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/2706:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2706:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2406:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/1/0821:08EDGAR2Form 8-K - Current report
2024/1/0821:00GLOBEMereo BioPharma Provides Update on Pipeline Progress and..
2024/1/0306:20EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0306:17EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0306:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0306:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0306:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0306:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0306:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/12/1906:16EDGAR2Form 8-A12B/A - Registration of securities [Section 12(b)]:..
2023/12/1906:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/3006:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/1621:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/2405:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/2405:01GLOBEMereo BioPharma Reports on Recent Program Developments and..
2023/10/1720:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/1505:30GLOBEUltragenyx and Mereo BioPharma Announce Interim Phase 2 Data..
2023/10/0921:00GLOBEUltragenyx to Present Setrusumab (UX143) Update at ASBMR..
2023/9/2120:00GLOBEMereo BioPharma to Participate in Fireside Chat at the 2023..
2023/9/2105:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/0720:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/0720:30GLOBEMereo BioPharma Reports Interim Financial Results for the..
2023/7/2705:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/7/0621:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/0621:00GLOBEUltragenyx Announces First Patients Dosed in Phase 3 Program..
2023/7/0105:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/5/3120:00GLOBEMereo BioPharma to Present at the Jefferies Healthcare..
2023/5/2402:43GLOBEPhase 2 Data from “ASTRAEUS” Trial of Mereo BioPharma’s..
2023/5/0901:46GLOBEMereo BioPharma Regains Compliance with Nasdaq Minimum Bid..
2023/5/0605:06GLOBEMereo BioPharma Announces Listing Transfer to Nasdaq Capital..

最近閲覧した銘柄

Delayed Upgrade Clock